Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 13,144 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06816121Recruiting
Blood test for early lung cancer in high-risk smokers
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
Oklahoma City, OklahomaAges 30–80 - NCT06816823RecruitingPhase 1
CAR-NK Cells for Advanced Pancreatic Cancer
This trial tests a new type of immunotherapy called CAR-NK cells (CL-NK-001) for patients with advanced pancreatic cancer that has a specific marker (eGR1). The goal is to see if these specially grown natural killer cells can attack the cancer after standard treatments have stopped working.
ShanghaiAges 18–70 - NCT06817174Recruiting
CT scan analysis for ovarian cancer treatment planning
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
LondonAges 18 years+ - NCT06817226Recruiting
Breast cancer decision tool study for Latinas
This study tests a decision-making tool for Latina breast cancer survivors or those at high risk. It aims to help you make informed choices about breast surgery and reconstruction options.
Chapel Hill, North CarolinaAges 18 years+ - NCT06817525RecruitingPhase 2
Chemo and immunotherapy before surgery for early triple-negative breast cancer
This trial tests whether a combination of chemotherapy drugs (nab-paclitaxel and carboplatin) plus an immunotherapy drug (PD1 inhibitor) given before surgery can help treat early-stage triple-negative breast cancer. It aims to improve outcomes by using these treatments before the main surgery.
Zhengzhou, HenanAges 18–65 - NCT06817954Recruiting
Breast reconstruction after mastectomy for breast cancer
This trial tests how safe and effective it is to remove the breast (mastectomy) and rebuild it right away during the same surgery. It is for women with early-stage breast cancer who want reconstruction instead of breast-sparing surgery.
Nanjing, JiangsuAges 18–75 - NCT06818149Recruiting
Studying heart inflammation from immunotherapy in lung cancer
This study looks for specific markers in the blood that can help doctors better understand and treat heart inflammation (myocarditis) caused by immunotherapy in people with lung cancer. If you join, you will help find ways to improve care for other patients.
ShanghaiAges 18 years+ - NCT06820333Recruiting
PSMA PET scan for newly diagnosed prostate cancer
This trial looks at how well a special scan called PSMA PET/CT can help find the spread of prostate cancer when it is first diagnosed. You may be able to join if your doctor has already recommended this scan for you.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT06821243Recruiting
Finding markers in HPV-related throat cancer to guide treatment
This study looks for certain markers in people with HPV-related throat cancer that could help doctors choose the best treatment. If you are planning to have surgery for your throat cancer, you may be able to join.
Rome, RomeAges 18 years+ - NCT06822036Recruiting
Starch powder to reduce bleeding in prostate surgery
This trial tests whether applying a dissolvable starch powder (Arister) inside the pelvis during robot-assisted prostate cancer surgery reduces post-surgery bleeding. It is for men whose surgeons plan to spare the nerves controlling erections and who have moderate erectile function beforehand.
Hamburg, Free and Hanseatic City of HamburgAges 45–68 - NCT06822530Recruiting
Increasing colon cancer screening after abnormal stool test
This trial tests a multilevel support program to help patients who had an abnormal FIT (fecal immunochemical test) result get a follow-up colonoscopy. The goal is to increase colorectal cancer screening completion.
Seattle, WashingtonAges 45–75 - NCT06822634Recruiting
Advanced imaging for rectal cancer treatment response
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
GlasgowAges 18 years+ - NCT06824818Recruiting
Can older men stop prostate cancer treatment early?
This study looks at whether men aged 70 or older who have been on hormone therapy for over 3 years can safely stop treatment. It aims to find out if stopping early helps maintain quality of life without letting the cancer come back.
Chicago, IllinoisAges 70 years+ - NCT06824974Recruiting
Time-restricted eating for liver disease or cancer
This study tests whether combining time-restricted eating with healthy eating helps people with metabolic liver disease, cirrhosis, or early-stage liver cancer. If you are overweight and currently fast less than 12 hours at night, this diet approach might improve your health.
La Jolla, CaliforniaAges 18 years+ - NCT06825624RecruitingPhase 1
Testing HS-20093 combinations for advanced colorectal cancer
This trial tests a new drug combination (HS-20093) for people with advanced colorectal cancer that has spread or cannot be removed by surgery. It aims to see if the combination is safe and effective.
Hangzhou, ZhejiangAges 18 years+ - NCT06826014Recruiting
Cancer prevention registry and biorepository study
This study creates a registry of people who have had certain cancer screenings or have conditions linked to cancer risk. Participants donate blood, urine, and cheek swab samples and allow their health records to be followed for five years to help future cancer research.
Bryan, TexasAges 18 years+ - NCT06826768RecruitingPhase 1
Study of REGN5678 plus cemiplimab for advanced prostate cancer
This trial tests a combination of two drugs (REGN5678 and cemiplimab) for men with metastatic castration-resistant prostate cancer that has progressed after at least two prior treatments. The goal is to see if this new combination can help shrink the cancer or slow its growth.
Houston, TexasAges 18 years+ - NCT06826885Recruiting
Comparing two types of radiation for breast cancer
This trial is testing how well two different radiation techniques, IMPT and IMRT, work for treating breast cancer. It aims to see which one is safer and more effective, so you might benefit from a potentially better treatment approach.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06828354RecruitingPhase 3
Study of SHR-A1811 for ovarian cancer
This trial tests a new drug called SHR-A1811 for ovarian cancer. It may help people whose cancer can be measured on scans and who are still well enough to do daily activities.
Wuhan, HubeiAges 18–75 - NCT06829095Recruiting
Nutrition counseling for esophageal and head and neck cancer patients
This trial tests whether personalized nutrition advice can improve the health of people with esophageal cancer or head and neck cancer who are getting chemoradiation. It may help you stay stronger and better manage treatment side effects.
New Taipei CityAges 18 years+ - NCT06829459RecruitingPhase 3
New drug combo vs chemo for resistant lung cancer
This trial tests a combination of two targeted drugs (Glumetinib and Osimertinib) against standard chemotherapy for people with non-small cell lung cancer that has stopped responding to initial targeted therapy. It may be an option if your tumor has a specific genetic change called MET amplification or overexpression.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06830083Recruiting
Shorter radiation schedule after mastectomy with implant reconstruction
This trial is testing a shorter, higher-dose radiation schedule (hypofractionation) for women who have had a mastectomy and immediate breast reconstruction with implants. The goal is to see if this approach works as well as standard radiation while possibly being more convenient and causing fewer side effects.
Nanjing, JiangsuAges 18–65 - NCT06830239RecruitingPhase 2
Neoadjuvant dostarlimab for resectable stage III colon cancer
This trial tests an investigational immunotherapy drug called dostarlimab given before surgery for colon cancer. It is for people whose tumor is MMR-proficient (also called MSS) and is large enough or has spread to nearby lymph nodes but not to other parts of the body. The goal is to see if this treatment can shrink the tumor before surgery.
LeuvenAges 18 years+ - NCT06830382Recruiting
HER2-PET scan for metastatic breast cancer treatment
This trial uses a special PET scan (HER2-PET) to see if a targeted drug (trastuzumab deruxtecan) works better for your type of metastatic breast cancer. The goal is to match the treatment to how much HER2 protein your tumors show.
SolnaAges 18 years+
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 13,144 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.